The NLRP3 inflammasome enhances lung adenocarcinoma cell A549 proliferation by activating the IL-1β/ERK/CREB and IL-18/AKT/CREK signaling pathways [31]. This evidence concerns the gene AKT1 and lung adenocarcinoma.